Grupo Clarin S.A. (GCLA)
Buenos Aires Exchange · Argentina · prices in ARS · close of 23 Oct 2026
Key indicators
| Last close | ARS 2,605.00 |
|---|---|
| 52-week range | 1,830.00 – 5,000.00 |
| Return, 1 month / 3 months | −29.6% / −34.5% |
| Return, 1 year / 3 years | +33.2% / +280.6% |
| Trend | Below its 200-day average |
| RSI (14) | 21 |
| Volatility (1 year) | 40.3% |
| Worst drawdown (1 year) | -46.5% |
| Average daily value traded | 4.89M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grupo Clarin is an Argentine media company based in Buenos Aires. It produces and distributes television and radio content, operates cable television networks, and publishes newspapers and magazines. Its customers include general audiences, advertisers and subscribers across Argentina and other Spanish-speaking markets. The company also provides printing services and runs the infrastructure behind its broadcasting operations, combining news and entertainment production with distribution through its own channels and platforms.
The shares are listed on the Buenos Aires Exchange in Argentina under the code GCLA, and the price on this page is in Argentine pesos (ARS). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grupo Clarin S.A. (GCLA) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 2,605.00 on 23 October 2026.
Its price-based Market X-Ray is 26 out of 100 (a weak price profile), ranking 133 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.2% and over the last three months it fell 34.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.2% | ||
| From 52-week high | -45.7% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -34.5% | ||
| 6-month return | -31.5% | ||
| 12-month return, skipping the last month | 89.3% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.5% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 4.89M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −10.6% |
|---|---|
| 1 month | −29.6% |
| 3 months | −34.5% |
| 6 months | −31.5% |
| 1 year | +33.2% |
| 3 years | +280.6% |
| 5 years | +3,220.6% |
Signals
| 50-day / 200-day average | 3,467.40 / 3,629.12 |
|---|---|
| Golden / death cross (60 days) | Death, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 169.31 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.